AcquisitionMethod: LC-MS/MS
AcquisitionMethod: liquid chromatography-tandem mass spectrometry
AcquisitionMethod: data-dependent MS/MS
AlkylationReagent: chloroacetamide
Chromatography: reversed-phase liquid chromatography (RP)
Chromatography: LC-MS/MS
Chromatography: C18
Chromatography: liquid chromatography
CleavageAgent: Lys-C
CleavageAgent: trypsin
Disease: Alzheimer's disease (AD)
Experiment: proteomics
Experiment: mass spectrometry
Experiment: MS
FactorValue: AD vs control
FactorValue: differentially expressed
FlowRate: 250 nl/min
FractionationMethod: HiRIEF
FragmentationMethod: Higher-energy collisional dissociation
FragmentationMethod: Collision-induced dissociation
GradientTime: 5 min
Instrument: ultra-high-performance liquid chromatography
Instrument: nanoLC
Instrument: ultimate 3000 RSLCnano system
Instrument: Thermo Fisher Scientific
Instrument: LTQ-Orbitrap
Instrument: Q Exactive HF mass spectrometer
Label: TMT10plex
MS2Analyzer: orbitrap
MissedCleavages: 2
MissedCleavages: maximum 2 missed cleavages
Modification: carbamidomethylation
Modification: oxidation
NumberOfFractions: 72
NumberOfSamples: 10 cases, five sporadic AD and five control cases
NumberOfTechnicalReplicates: No technical replicates were performed
Organism: Homo sapiens
OrganismPart: superior temporal cortex
OrganismPart: prefrontal cortex
OrganismPart: neocortex
OrganismPart: inferior temporal cortex
OrganismPart: hippocampus
OrganismPart: temporal cortex
OrganismPart: temporal lobe
OrganismPart: brain
OrganismPart: dentate gyrus
QuantificationMethod: TMT
QuantificationMethod: TMT10plex
ReductionReagent: DTT
ReductionReagent: dithiothreitol
SearchEngine: Percolator
SearchEngine: MS-GF+
Separation: isoelectric focusing
Separation: liquid chromatography-mass spectrometry
Separation: HiRIEF
TechnologyType: LC-MS/MS
Temperature: -20 degreesC
Temperature: 95 degreesC